Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians.

To evaluate the outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment (NMIBC) in elderly patients over 80 years of age.

This is a retrospective single tertiary-centre study.